Barinthus Biotherapeutics Statistics

Total Valuation

BRNS has a market cap or net worth of $42.36 million. The enterprise value is -$56.30 million.

Market Cap	42.36M
Enterprise Value	-56.30M

Important Dates

The last earnings date was Thursday, March 20, 2025, before market open.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

BRNS has 40.34 million shares outstanding. The number of shares has increased by 2.51% in one year.

Current Share Class	n/a
Shares Outstanding	40.34M
Shares Change (YoY)	+2.51%
Shares Change (QoQ)	+1.87%
Owned by Insiders (%)	11.88%
Owned by Institutions (%)	24.48%
Float	25.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.76
Forward PS	n/a
PB Ratio	0.32
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.09.

Current Ratio	8.03
Quick Ratio	7.52
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-861.36

Financial Efficiency

Return on equity (ROE) is -38.59% and return on invested capital (ROIC) is -16.68%.

Return on Equity (ROE)	-38.59%
Return on Assets (ROA)	-15.22%
Return on Invested Capital (ROIC)	-16.68%
Return on Capital Employed (ROCE)	-31.56%
Revenue Per Employee	$115,146
Profits Per Employee	-$469,800
Employee Count	130
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	-44,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.94% in the last 52 weeks. The beta is -0.80, so BRNS's price volatility has been lower than the market average.

Beta (5Y)	-0.80
52-Week Price Change	-54.94%
50-Day Moving Average	1.02
200-Day Moving Average	1.21
Relative Strength Index (RSI)	53.86
Average Volume (20 Days)	11,267

Short Selling Information

Short Interest	14,775
Short Previous Month	11,255
Short % of Shares Out	0.06%
Short % of Float	n/a
Short Ratio (days to cover)	0.67

Income Statement

In the last 12 months, BRNS had revenue of $14.97 million and -$61.07 million in losses. Loss per share was -$1.55.

Revenue	14.97M
Gross Profit	13.29M
Operating Income	-45.65M
Pretax Income	-65.25M
Net Income	-61.07M
EBITDA	-43.05M
EBIT	-45.65M
Loss Per Share	-$1.55

Full Income Statement

Balance Sheet

The company has $110.66 million in cash and $12.01 million in debt, giving a net cash position of $98.66 million or $2.45 per share.

Cash & Cash Equivalents	110.66M
Total Debt	12.01M
Net Cash	98.66M
Net Cash Per Share	$2.45
Equity (Book Value)	130.14M
Book Value Per Share	3.23
Working Capital	110.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.94 million and capital expenditures -$892,000, giving a free cash flow of -$29.83 million.

Operating Cash Flow	-28.94M
Capital Expenditures	-892,000
Free Cash Flow	-29.83M
FCF Per Share	-$0.74

Full Cash Flow Statement

Margins

Gross Margin	88.78%
Operating Margin	-304.98%
Pretax Margin	-409.03%
Profit Margin	n/a
EBITDA Margin	-287.61%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRNS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.51%
Shareholder Yield	n/a
Earnings Yield	-144.19%
FCF Yield	-70.43%

Analyst Forecast

The average price target for BRNS is $3.00, which is 185.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	185.71%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BRNS has an Altman Z-Score of -0.64 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.64
Piotroski F-Score	3